Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

103 recruiting

Chronic Obstructive Pulmonary Disease (COPD) Trials at a Glance

74 actively recruiting trials for chronic obstructive pulmonary disease (copd) are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 19 trials, with the heaviest enrollment activity in Baltimore, Hong Kong, and Houston. Lead sponsors running chronic obstructive pulmonary disease (copd) studies include AstraZeneca, ADIR Association, and Beijing Chao Yang Hospital.

Browse chronic obstructive pulmonary disease (copd) trials by phase

Treatments under study

About Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Looking for clinical trials for Chronic Obstructive Pulmonary Disease (COPD)? There are currently 103 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Obstructive Pulmonary Disease (COPD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Obstructive Pulmonary Disease (COPD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 74 trials

Recruiting

Study of Patient With Frequent Exacerbations in Moscow

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca500 enrolled1 locationNCT07307781
Recruiting
Phase 2

Phase II Study of RC1416 Injection in COPD

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled41 locationsNCT07402551
Recruiting

Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness

Chronic Obstructive Pulmonary Disease (COPD)PneumoniaInfection+6 more
National University Hospital, Singapore220 enrolled1 locationNCT07536035
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled268 locationsNCT06878261
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled298 locationsNCT06883305
Recruiting
Not Applicable

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

Heart FailureCancerDiabetes+4 more
Amager Hospital2,800 enrolled1 locationNCT07518446
Recruiting
Not Applicable

Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program

Chronic Obstructive Pulmonary Disease (COPD)Frailty
National Geriatric Hospital80 enrolled2 locationsNCT07519603
Recruiting
Phase 3

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Not Applicable

Acute Effect of Different Frequency of Whole Body Vibration (WBV) on Healthy and Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)Whole Body Vibration
National Cheng Kung University102 enrolled1 locationNCT07509606
Recruiting

Comparison of Clinical Status of Individuals With COPD and Preserved Ratio Impaired Spirometry

Chronic Obstructive Pulmonary Disease (COPD)Preserved Ratio Impaired Spirometry (PRISM)
Hacettepe University54 enrolled1 locationNCT06682832
Recruiting
Phase 1Phase 2

cfMSC Stem Cell Therapy Targeting COPD

Chronic Obstructive Pulmonary Disease (COPD)
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT07477600
Recruiting
Early Phase 1

Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy

Chronic Obstructive Pulmonary Disease (COPD)
Regend Therapeutics12 enrolled1 locationNCT07355868
Recruiting

IMPACT COPD Cohort (China)

Chronic Obstructive Pulmonary Disease (COPD)Multimorbidities
Beijing Chao Yang Hospital10,000 enrolled4 locationsNCT07382986
Recruiting
Phase 4

Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Chronic Obstructive Pulmonary Disease (COPD)
Copenhagen Respiratory Research2,000 enrolled14 locationsNCT06892210
Recruiting
Phase 2

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting

Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases

Chronic Obstructive Pulmonary Disease (COPD)Asthma (Diagnosis)Chronic Airway Diseases
Beijing Chao Yang Hospital950 enrolled1 locationNCT07472738
Recruiting
Not Applicable

Effects Of Low-Load Blood Flow Restriction Training Of The Upper Extremity In Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)Blood Flow Restriction Training (BFRT)
Inonu University36 enrolled1 locationNCT07469111
Recruiting
Not Applicable

Remote Monitoring of COPD Patients Experiencing an Acute Exacerbation Through Health Evaluations Using Wearable Mobile Technology

Chronic Obstructive Pulmonary Disease (COPD)Acute Exacerbation of COPD
David Ruttens50 enrolled1 locationNCT06890767
Recruiting
Phase 2

Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)
RSUP Persahabatan20 enrolled1 locationNCT07441226
Recruiting

Implementation of digitally-supported self-management and pulmonary rehabilitation in people with chronic respiratory disease

AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+1 more
Northern Sydney Local Health District138 enrolled3 locationsACTRN12626000197336